エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/26 | 3,350 | 3,350 | 3,290 | 3,305 | ±0 | ±0% | 8,400 |
2022/08/25 | 3,285 | 3,315 | 3,270 | 3,305 | +20 | +0.6% | 6,400 |
2022/08/24 | 3,220 | 3,285 | 3,205 | 3,285 | +60 | +1.9% | 7,300 |
2022/08/23 | 3,280 | 3,300 | 3,225 | 3,225 | -65 | -2% | 14,200 |
2022/08/22 | 3,320 | 3,345 | 3,270 | 3,290 | -70 | -2.1% | 13,300 |
2022/08/19 | 3,420 | 3,425 | 3,345 | 3,360 | -60 | -1.8% | 10,000 |
2022/08/18 | 3,305 | 3,430 | 3,275 | 3,420 | +85 | +2.5% | 25,300 |
2022/08/17 | 3,390 | 3,410 | 3,330 | 3,335 | -65 | -1.9% | 17,200 |
2022/08/16 | 3,455 | 3,575 | 3,400 | 3,400 | ±0 | ±0% | 29,000 |
2022/08/15 | 3,550 | 3,550 | 3,400 | 3,400 | -90 | -2.6% | 20,400 |
2022/08/12 | 3,480 | 3,490 | 3,420 | 3,490 | +105 | +3.1% | 20,400 |
2022/08/10 | 3,435 | 3,450 | 3,355 | 3,385 | -100 | -2.9% | 21,600 |
2022/08/09 | 3,455 | 3,510 | 3,390 | 3,485 | +30 | +0.9% | 17,600 |
2022/08/08 | 3,515 | 3,565 | 3,405 | 3,455 | -165 | -4.6% | 41,600 |
2022/08/05 | 3,820 | 3,820 | 3,620 | 3,620 | -260 | -6.7% | 52,900 |
2022/08/04 | 3,945 | 3,995 | 3,880 | 3,880 | ±0 | ±0% | 23,300 |
2022/08/03 | 3,780 | 3,880 | 3,750 | 3,880 | +120 | +3.2% | 16,600 |
2022/08/02 | 3,740 | 3,810 | 3,715 | 3,760 | -15 | -0.4% | 12,500 |
2022/08/01 | 3,695 | 3,775 | 3,650 | 3,775 | +80 | +2.2% | 9,600 |
2022/07/29 | 3,685 | 3,730 | 3,650 | 3,695 | +10 | +0.3% | 13,400 |
2022/07/28 | 3,540 | 3,685 | 3,540 | 3,685 | +145 | +4.1% | 36,200 |
2022/07/27 | 3,515 | 3,600 | 3,490 | 3,540 | +40 | +1.1% | 13,600 |
2022/07/26 | 3,590 | 3,605 | 3,475 | 3,500 | -65 | -1.8% | 22,400 |
2022/07/25 | 3,550 | 3,565 | 3,440 | 3,565 | +75 | +2.1% | 13,700 |
2022/07/22 | 3,630 | 3,675 | 3,490 | 3,490 | -145 | -4% | 26,500 |
2022/07/21 | 3,570 | 3,760 | 3,570 | 3,635 | +65 | +1.8% | 33,500 |
2022/07/20 | 3,645 | 3,645 | 3,530 | 3,570 | +90 | +2.6% | 28,900 |
2022/07/19 | 3,525 | 3,525 | 3,400 | 3,480 | -75 | -2.1% | 19,200 |
2022/07/15 | 3,580 | 3,615 | 3,495 | 3,555 | -25 | -0.7% | 18,700 |
2022/07/14 | 3,525 | 3,605 | 3,485 | 3,580 | +55 | +1.6% | 15,700 |
2022/07/13 | 3,540 | 3,570 | 3,450 | 3,525 | -15 | -0.4% | 9,200 |
2022/07/12 | 3,510 | 3,545 | 3,430 | 3,540 | +30 | +0.9% | 18,700 |
2022/07/11 | 3,705 | 3,755 | 3,510 | 3,510 | -140 | -3.8% | 16,100 |
2022/07/08 | 3,635 | 3,735 | 3,600 | 3,650 | +60 | +1.7% | 30,200 |
2022/07/07 | 3,680 | 3,680 | 3,530 | 3,590 | -90 | -2.4% | 27,000 |
2022/07/06 | 3,660 | 3,770 | 3,615 | 3,680 | -20 | -0.5% | 14,800 |
2022/07/05 | 3,660 | 3,715 | 3,615 | 3,700 | +10 | +0.3% | 15,600 |
2022/07/04 | 3,685 | 3,780 | 3,600 | 3,690 | +50 | +1.4% | 21,300 |
2022/07/01 | 3,750 | 3,795 | 3,615 | 3,640 | -65 | -1.8% | 26,300 |
2022/06/30 | 3,800 | 3,820 | 3,705 | 3,705 | -130 | -3.4% | 23,700 |
2022/06/29 | 3,680 | 3,845 | 3,660 | 3,835 | +25 | +0.7% | 25,800 |
2022/06/28 | 3,595 | 3,835 | 3,555 | 3,810 | +160 | +4.4% | 50,300 |
2022/06/27 | 3,770 | 3,770 | 3,615 | 3,650 | -70 | -1.9% | 23,100 |
2022/06/24 | 3,715 | 3,805 | 3,710 | 3,720 | +75 | +2.1% | 36,100 |
2022/06/23 | 3,600 | 3,705 | 3,540 | 3,645 | +85 | +2.4% | 24,700 |
2022/06/22 | 3,510 | 3,570 | 3,460 | 3,560 | +50 | +1.4% | 20,300 |
2022/06/21 | 3,350 | 3,540 | 3,350 | 3,510 | +160 | +4.8% | 23,800 |
2022/06/20 | 3,410 | 3,410 | 3,175 | 3,350 | -60 | -1.8% | 33,000 |
2022/06/17 | 3,335 | 3,425 | 3,285 | 3,410 | +5 | +0.1% | 35,000 |
2022/06/16 | 3,520 | 3,590 | 3,395 | 3,405 | -65 | -1.9% | 28,500 |
551~
600
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム